Back to Search
STEVE BOGEN, M.D., PH.D.
M.D., PH.D.
Clinical Pathology/Laboratory Medicine Physician
NPI: 1598738551IndividualAccepts Medicare
Specialties, Licenses & Credentials
Clinical Pathology/Laboratory Medicine PhysicianPrimary
Pathology — Clinical Pathology/Laboratory Medicine
Code: 207ZP0105X
58406(MA)
CMS Specialties
PrimaryPATHOLOGY
Education
UNIVERSITY OF CHICAGO, PRITZKER SCHOOL OF MEDICINE
Class of 1986
Research & Publications (20)
Discovery of novel P3 sulfonamide-capped inhibitors of HCV NS3 protease. Inhibitors with improved cellular potencies.
PMID 19481946·Bioorg Med Chem·2009
7-preclinical
Toward the back-up of boceprevir (SCH 503034): discovery of new extended P4-capped ketoamide inhibitors of hepatitis C virus NS3 serine protease with improved potency and pharmacokinetic profiles.
PMID 19456105·J Med Chem·2009
7-preclinical
Toward second generation hepatitis C virus NS3 serine protease inhibitors: discovery of novel P4 modified analogues with improved potency and pharmacokinetic profile.
PMID 19371095·J Med Chem·2009
7-preclinical
Second-generation highly potent and selective inhibitors of the hepatitis C virus NS3 serine protease.
PMID 19196021·J Med Chem·2009
7-preclinical
Design, synthesis, and evaluation of oxygen-containing macrocyclic peptidomimetics as inhibitors of HCV NS3 protease.
PMID 19154150·J Med Chem·2009
8-other
Discovery and structure-activity relationship of P1-P3 ketoamide derived macrocyclic inhibitors of hepatitis C virus NS3 protease.
PMID 19102654·J Med Chem·2009
8-other
Experimental validation of peptide immunohistochemistry controls.
PMID 19077907·Appl Immunohistochem Mol Morphol·2009
4-observational
Hepatitis C virus NS3-4A serine protease inhibitors: SAR of new P1 derivatives of SCH 503034.
PMID 18547808·Bioorg Med Chem Lett·2008
8-other
Key steps in the structure-based optimization of the hepatitis C virus NS3/4A protease inhibitor SCH503034.
PMID 18421139·J Synchrotron Radiat·2008
8-other
National HER2 proficiency test results using standardized quantitative controls: characterization of laboratory failures.
PMID 18251579·Arch Pathol Lab Med·2008
8-other
Characterization of resistance mutations against HCV ketoamide protease inhibitors.
PMID 18201776·Antiviral Res·2008
8-other
Correlation between PAMPA permeability and cellular activities of hepatitis C virus protease inhibitors.
PMID 18164692·Biochem Pharmacol·2008
8-other
Bioinformatic requirements for protein database searching using predicted epitopes from disease-associated antibodies.
PMID 17897933·Mol Cell Proteomics·2008
8-other
Accurate identification of paraprotein antigen targets by epitope reconstruction.
PMID 17878398·Blood·2008
8-other
Discovery of the HCV NS3/4A protease inhibitor (1R,5S)-N-[3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3- [2(S)-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]- 6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(S)-carboxamide (Sch 503034) II. Key steps in structure-based optimization.
PMID 17444623·J Med Chem·2007
8-other
In vitro antiviral activity of SCH446211 (SCH6), a novel inhibitor of the hepatitis C virus NS3 serine protease.
PMID 17151003·J Antimicrob Chemother·2007
8-other
A high throughput combinatorial library technique for identifying formalin-sensitive epitopes.
PMID 17056057·J Immunol Methods·2006
8-other
Discovery of (1R,5S)-N-[3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]- 3-[2(S)-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]- 6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(S)-carboxamide (SCH 503034), a selective, potent, orally bioavailable hepatitis C virus NS3 protease inhibitor: a potential therapeutic agent for the treatment of hepatitis C infection.
PMID 17004721·J Med Chem·2006
7-preclinical
Clinical laboratory measurement of serum, plasma, and blood viscosity.
PMID 16830959·Am J Clin Pathol·2006
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 800 WASHINGTON ST, TUFTS MEDICAL CENTER
BOSTON, MA 02111 - Phone
- (617) 636-1112
Quick Facts
- NPI
- 1598738551
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 40
- Publications
- 20
Are you this provider?
Claim Your Profile